Allegheny Health Network's 'Alcohol Bridge Clinic' Transforms Treatment of Alcohol-Associated Liver Disease Multidisciplinary clinic shows early success in helping patients achieve sobriety and ...

GlaxoSmithKline (GSK) announced an update on their ongoing clinical study.

Cytotheryx, a growing Rochester biotech firm working on treatments for liver disease, recently received $60 million in ...

People with compromised liver function may be able to reduce their risk of liver cancer or slow its progression with a simple dietary change: eating less protein. A Rutgers-led study in Science ...

Fatty liver disease happens when too much fat builds up in the liver. Metabolic dysfunction-associated steatohepatitis (MASH) is a severe type of fatty liver disease where fat buildup causes liver ...

Liver cancer, primarily hepatocellular carcinoma, originates in the liver, with hepatitis B and C as major risk factors. Diagnosis involves physical exams, blood tests, imaging, and possibly biopsy to ...

A groundbreaking international trial has found that semaglutide, a drug best known for treating diabetes and obesity, can also reverse a dangerous liver disease called MASH in nearly two-thirds of ...

The diabetes and weight loss drug semaglutide may also reverse signs of liver disease. That’s the headline result of a new clinical trial that tested the popular medication in patients with MASH, or ...

More than 30% of people worldwide have metabolic dysfunction–associated steatotic liver disease (MASLD; formerly nonalcoholic fatty liver disease), including 65% of those with type 2 diabetes (T2D) ...

Under the theme of Early Detection Drives Direction, Global Liver Institute’s annual #RareAware campaign challenges health systems, policymakers, and communities to recognize rare liver diseases ...

Researchers from the Cancer Research UK Scotland Institute in Glasgow have discovered why certain cancer-causing genes trigger tumours only in specific tissues, focusing on the bowel and liver.

Liver cancer remains a significant global health challenge and can develop silently in patients who are unaware they have underlying liver disease. To discuss this unmet need in cancer care, CURE sat ...